E

Encoded Therapeutics

Precision gene therapies for pediatric CNS.

Director Clinical Development - Gene Therapy

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • An MD, DO, or equivalent international medical degree is required.
  • At least 3 years of biotech or pharmaceutical clinical development experience is required for the Director level; 1 or more years will be considered for the Associate Director level. Equivalent academic physician-scientist experience leading clinical trials as a principal investigator will also be considered.
  • Demonstrated experience designing and executing clinical trials, including vendor management, is required at the Director level.
  • Ability to communicate efficiently with scientists, thought leaders, investigators, and executive management.
  • Experience in medical monitoring, evaluating potential dose-limiting toxicities, pharmacovigilance, and Good Clinical Practice/International Council for Harmonisation regulatory compliance.
  • For the Director level, experience managing direct reports, leading cross-functional project teams, and building collaborative relationships with key opinion leaders. For the Associate Director level, readiness to mentor junior staff and coordinate across clinical and operational functions.
  • Strong oral and written communication skills and a track record of translating complex clinical data into presentations, regulatory documents, and peer-reviewed publications.
  • Ability to collaborate and interact with internal stakeholders across Regulatory Affairs, Medical Affairs, Clinical Operations, Biometrics, Research, and Translational Science.
  • Computer skills, including Microsoft Office Suite, industry-standard electronic data capture systems such as RAVE and InForm, and data analysis and presentation software.
  • Ability to travel up to 25% for investigator meetings, site visits, medical conferences, and regulatory meetings, potentially including international travel.

Responsibilities

  • Support clinical development strategy for programs targeting chronic neuropathic pain in partnership with senior Clinical Development leadership.
  • Lead activities related to Phase 1–4 clinical trials, including authoring and reviewing protocols, investigator brochures, and clinical study reports, and managing contract research organizations.
  • Define, plan, and provide medical monitoring, including evaluation of participant eligibility, safety, and efficacy across ongoing and completed studies for Dravet syndrome and chronic neuropathic pain.
  • Review adverse events, monitor real-time safety data, prepare analyses and clinical input for regulatory submissions, and lead data interpretation with pharmacovigilance contract research organization partners.
  • Represent Clinical Development in Data Monitoring Committee safety reviews, evaluate potential dose-limiting toxicities, and ensure continuous safety monitoring across the clinical portfolio.
  • Work with the Eligibility Review Committee to evaluate complex screening data and confirm participant eligibility across ongoing clinical programs.
  • Build and cultivate relationships with key opinion leaders, principal investigators, pediatric clinical trial networks, outcomes experts, and patient advocacy organizations to inform trial endpoints and support patient recruitment.
  • Lead investigator meetings and site initiation visits, and partner with Clinical Operations and Medical Affairs to drive enrollment in clinical studies.
  • For direct reports, define roles, responsibilities, and performance objectives; provide feedback; recognize achievements; and identify opportunities for growth and improvement.
  • Provide clinical development support for multiple gene therapy programs across different stages of the drug development lifecycle, initially supporting ETX301 and pharmacovigilance and medical monitoring for ETX101.
  • Support investigator management, collaborate in regulatory interactions and patient advocacy outreach, and contribute subject matter expertise to content and publications.

Desired Qualifications

  • Experience overseeing protocol-mandated prophylactic immunomodulation regimens, such as glucocorticoids, to mitigate immune-mediated responses.
  • Board certification or eligibility in Pain Medicine, Pediatric or Adult Neurology, Medical Genetics, Physical Medicine and Rehabilitation, Psychiatry, or related fields.
  • Specific experience in gene therapies, rare disease, epilepsy, chronic pain management, medical monitoring, and pharmacovigilance.
  • A strong track record in team leadership, development of clinical-regulatory strategies, and/or industry-academic collaborations.
  • Experience providing direct clinical input for regulatory submissions and participating in engagement with global health authorities, including the FDA and EMA.
  • Knowledge of AAV gene or cell therapy class-specific risks, including immunogenicity, safety evaluations for dorsal root ganglionopathy or hepatotoxicity, and long-term follow-up requirements such as five-year follow-up.

About the Company

Encoded Therapeutics

Precision gene therapies for pediatric CNS.

Encoded Therapeutics develops precision gene therapies for pediatric CNS disorders such as Dravet syndrome, using a targeting and regulation platform that directs genetic payloads to specific brain cell types based on genetic profiles. The approach aims to increase gene specificity, cell selectivity, and potency, while reducing off-target effects and toxicity. Therapies are designed to modify disease-causing genes in defined brain cells to provide lasting benefits. The company plans to translate these therapies into clinically effective treatments and commercialize them through partnerships with healthcare providers.

Company size
51-200
Company stage
Series F
Total funding
$514.1M
Headquarters
San Francisco, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at Encoded Therapeutics

See more jobs